Elevated levels of circulating prolactin (hyperprolactinemia) have long been associated with pituitary tumors [20], but more recently prolactin has been reported in association with a variety of additional cancers, including breast [21]–[23], prostate [24], and colon carcinoma [25]. This evidence concerns the gene PRL and pituitary tumor.